{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:43:10Z","timestamp":1778910190759,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T00:00:00Z","timestamp":1261612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T00:00:00Z","timestamp":1261612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1038\/gt.2009.160","type":"journal-article","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T11:43:08Z","timestamp":1261654988000},"page":"521-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Neonatal gene transfer using lentiviral vector for murine Pompe disease: long-term expression and glycogen reduction"],"prefix":"10.1038","volume":"17","author":[{"given":"S O","family":"Kyosen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Ida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,24]]},"reference":[{"key":"BFgt2009160_CR1","volume-title":"Glycogen Storage Disease Type II (GSDII)","author":"R Hirschhorn","year":"2001","unstructured":"Hirschhorn R, Reuser AJJ . Glycogen Storage Disease Type II (GSDII). McGraw-Hill: New York, 2001."},{"key":"BFgt2009160_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/1566524024605789","volume":"2","author":"N Raben","year":"2002","unstructured":"Raben N, Plotz P, Byrne BJ . Acid alpha-glucosidase deficiency (Glycogenosis type II, Pompe disease). Curr Mol Med 2002; 2: 145\u2013166.","journal-title":"Curr Mol Med"},{"key":"BFgt2009160_CR3","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","volume":"144","author":"PS Kishnani","year":"2004","unstructured":"Kishnani PS, Howell R . Pompe disease in infants and children. J Pediatr 2004; 144: S35\u2013S43.","journal-title":"J Pediatr"},{"key":"BFgt2009160_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","volume":"148","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D . A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 2006; 148: 671\u2013675.","journal-title":"J Pediatr"},{"key":"BFgt2009160_CR5","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"A Van der Ploeg","year":"2008","unstructured":"Van der Ploeg A, Reuser AJJ . Pompe's disease. Lancet 2008; 372: 1342\u20131353.","journal-title":"Lancet"},{"key":"BFgt2009160_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","volume":"149","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Nicolino M, Voit T, Rogers RC, Tsai AC-H, Waterson J et al. Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. J Pediatr 2006; 149: 89\u201397.","journal-title":"J Pediatr"},{"key":"BFgt2009160_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL et al. Recombinant human acid alpha-glucosidase. Major clinical benefits in infantile-onset Pompe disease. Neurology 2007; 68: 99\u2013109.","journal-title":"Neurology"},{"key":"BFgt2009160_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/CND.0b013e318176dbe4","volume":"9","author":"LW Katzin","year":"2008","unstructured":"Katzin LW, Amato AA . A review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. J Clin Neuromuscul Dis 2008; 9: 421\u2013431.","journal-title":"J Clin Neuromuscul Dis"},{"key":"BFgt2009160_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1006\/mthe.2002.0563","volume":"5","author":"E Ding","year":"2002","unstructured":"Ding E, Hu H, Hodges BL, Migone F, Serra D, Xu F et al. Efficacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is critically dependent on vector dose, transgene promoter, and the tissues targeted for vector transduction. Mol Ther 2002; 5: 436\u2013446.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1006\/mthe.2002.0580","volume":"5","author":"TJ Fraites Jr","year":"2002","unstructured":"Fraites Jr TJ, Schleissing MR, Shanely RA, Walter GA, Cloutier DA, Zolotukhin I et al. Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors. Mol Ther 2002; 5: 571\u2013578.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1089\/hum.2005.16.68","volume":"16","author":"KO Cresawn","year":"2005","unstructured":"Cresawn KO, Fraites Jr TJ, Wasserfall C, Atkinson M, Lewis M, Porvasnik S et al. Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type II. Hum Gene Ther 2005; 16: 68\u201380.","journal-title":"Hum Gene Ther"},{"key":"BFgt2009160_CR12","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ymthe.2005.04.024","volume":"12","author":"LM Franco","year":"2005","unstructured":"Franco LM, Sun B, Yang X, Bird A, Zhang H, Schneider A et al. Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II. Mol Ther 2005; 12: 876\u2013884.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.ymthe.2005.01.012","volume":"11","author":"B Sun","year":"2005","unstructured":"Sun B, Zhang H, Franco LM, Brown T, Bird A, Schneider A et al. Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter. Mol Ther 2005; 11: 889\u2013898.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1089\/hum.2008.010","volume":"19","author":"RJ Ziegler","year":"2008","unstructured":"Ziegler RJ, Bercury SD, Fidler J, Zhao MA, Foley J, Taksir TV et al. Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice. Hum Gene Ther 2008; 19: 609\u2013621.","journal-title":"Hum Gene Ther"},{"key":"BFgt2009160_CR15","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/mt.2008.133","volume":"16","author":"B Sun","year":"2008","unstructured":"Sun B, Young SP, Li P, Di C, Brown T, Salva MZ et al. Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy. Mol Ther 2008; 16: 1366\u20131371.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR16","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/sj.gt.3302550","volume":"12","author":"C Mah","year":"2005","unstructured":"Mah C, Cresawn KO, Fraites Jr TJ, Pacak CA, Lewis MA, Zolotukhin I et al. Sustained correction of glycogen storage disease type II using adeno-associated virus serotype 1 vectors. Gene Therapy 2005; 12: 1405\u20131409.","journal-title":"Gene Therapy"},{"key":"BFgt2009160_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/sj.mt.6300100","volume":"15","author":"C Mah","year":"2007","unstructured":"Mah C, Pacak CA, Cresawn KO, DeRuisseau LR, Germain S, Lewis MA et al. Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors. Mol Ther 2007; 15: 501\u2013507.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1089\/hum.2005.16.1133","volume":"16","author":"A Biffi","year":"2005","unstructured":"Biffi A, Naldini L . Gene therapy of storage disorders by retroviral and lentiviral vectors. Hum Gene Ther 2005; 16: 1133\u20131142.","journal-title":"Hum Gene Ther"},{"key":"BFgt2009160_CR19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","volume":"11","author":"H Kobayashi","year":"2005","unstructured":"Kobayashi H, Carbonaro D, Pepper K, Petersen D, Ge S, Jackson H et al. Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Mol Ther 2005; 11: 776\u2013789.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11626-008-9138-5","volume":"44","author":"E Richard","year":"2008","unstructured":"Richard E, Douillard-Guilloux G, Batista L, Caillaud C . Correction of glycogenosis type 2 by muscle-specific lentiviral vector. In Vitro Cell Dev Biol Anim 2008; 44: 397\u2013406.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"BFgt2009160_CR21","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/sj.mt.6300180","volume":"15","author":"T Kimura","year":"2007","unstructured":"Kimura T, Koya RC, Anselmi L, Sternini C, Wang H-J, Comin-Anduix B et al. Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression. Mol Ther 2007; 15: 1390\u20131399.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR22","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463\u20138471.","journal-title":"J Virol"},{"key":"BFgt2009160_CR23","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1086\/522236","volume":"81","author":"B Sun","year":"2007","unstructured":"Sun B, Bird A, Young SP, Kishnani PS, Chen Y-T, Koeberl DD . Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance. Am J Hum Genet 2007; 81: 1042\u20131049.","journal-title":"Am J Hum Genet"},{"key":"BFgt2009160_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymgme.2008.03.008","volume":"94","author":"T Ohashi","year":"2008","unstructured":"Ohashi T, Iizuka S, Ida H, Eto Y . Reduced alpha-Gal A enzyme activity in Fabry fibroblast cells and Fabry mice tissues induced by serum from antibody positive patients with Fabry disease. Mol Genet Metab 2008; 94: 313\u2013318.","journal-title":"Mol Genet Metab"},{"key":"BFgt2009160_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1089\/hum.2005.16.68","volume":"16","author":"KO Cresawn","year":"2005","unstructured":"Cresawn KO, Fraites Jr TJ, Wasserfall C, Atkinson M, Lewis M, Porvasnik S et al. Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type II. Hum Gene Ther 2005; 16: 68\u201380.","journal-title":"Hum Gene Ther"},{"key":"BFgt2009160_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1022998010833","volume":"12","author":"N Raben","year":"2003","unstructured":"Raben N, Nagaraju K, Lee A, Lu N, Rivera Y, Jatkar T et al. Induction of tolerance to a recombinant human enzyme, acid alpha-glucosidase, in enzyme deficient knockout mice. Transgenic Res 2003; 12: 171\u2013178.","journal-title":"Transgenic Res"},{"key":"BFgt2009160_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1365-2249.2008.03602.x","volume":"152","author":"A Joseph","year":"2008","unstructured":"Joseph A, Munroe K, Housman M, Garman R, Richards S . Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model. Clin Exp Immunol 2008; 152: 138\u2013146.","journal-title":"Clin Exp Immunol"},{"key":"BFgt2009160_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/156652307782151434","volume":"7","author":"KP Ponder","year":"2007","unstructured":"Ponder KP . Immunology of neonatal gene transfer. Curr Gene Ther 2007; 7: 403\u2013410.","journal-title":"Curr Gene Ther"},{"key":"BFgt2009160_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ymthe.2006.03.015","volume":"14","author":"KP Ponder","year":"2006","unstructured":"Ponder KP, Wang B, Wang P, Ma X, Herati R, Wang B et al. Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig. Mol Ther 2006; 14: 5\u201313.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR30","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1073\/pnas.96.5.2296","volume":"96","author":"TM Daly","year":"1999","unstructured":"Daly TM, Vogler C, Levy B, Haskins ME, Sands MS . Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc Natl Acad Sci USA 1999; 96: 2296\u20132300.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2009160_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","volume":"12","author":"CS Manno","year":"2006","unstructured":"Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJE et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006; 12: 342\u2013347.","journal-title":"Nat Med"},{"key":"BFgt2009160_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/1521-2254(200009\/10)2:5<308::AID-JGM131>3.0.CO;2-3","volume":"2","author":"E Vigna","year":"2000","unstructured":"Vigna E, Naldini L . Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2000; 2: 308\u2013316.","journal-title":"J Gene Med"},{"key":"BFgt2009160_CR33","doi-asserted-by":"publisher","first-page":"17372","DOI":"10.1073\/pnas.0608138103","volume":"103","author":"BL Levine","year":"2006","unstructured":"Levine BL, Humeau LM, Boyer J, MacGregor RR, Rebello T, Lu X et al. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 2006; 103: 17372\u201317377.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2009160_CR34","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1089\/hum.2006.17.1112","volume":"17","author":"C Di Domenico","year":"2006","unstructured":"Di Domenico C, Di Napoli D, Gonzalez y Reyero E, Lombardo A, Naldini L, Di Natale P . Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy. Hum Gene Ther 2006; 17: 1112\u20131121.","journal-title":"Hum Gene Ther"},{"key":"BFgt2009160_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ymgme.2007.11.008","volume":"93","author":"C McIntyre","year":"2008","unstructured":"McIntyre C, Roberts ALD, Ranieri E, Clements PR, Byers S, Anson DS . Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA. Mol Genet Metab 2008; 93: 411\u2013418.","journal-title":"Mol Genet Metab"},{"key":"BFgt2009160_CR36","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.gt.3302839","volume":"14","author":"M Yoshimitsu","year":"2007","unstructured":"Yoshimitsu M, Higuchi K, Ramsubir S, Nonaka T, Rasaiah VI, Siatskas C et al. Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem\/progenitor cells. Gene Therapy 2007; 14: 256\u2013265.","journal-title":"Gene Therapy"},{"key":"BFgt2009160_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/jgm.1305","volume":"11","author":"G Douillard-Guilloux","year":"2009","unstructured":"Douillard-Guilloux G, Richard E, Batista L, Caillaud C . Partial phenotipic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease. J Gene Med 2009; 11: 279\u2013287.","journal-title":"J Gene Med"},{"key":"BFgt2009160_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1096\/fj.05-4551fje","volume":"20","author":"M Krishnan","year":"2006","unstructured":"Krishnan M, Park JM, Cao F, Wang D, Paulmurugan R, Tseng JR et al. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J 2006; 20: 106\u2013108.","journal-title":"FASEB J"},{"key":"BFgt2009160_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4161\/auto.2984","volume":"2","author":"T Fukuda","year":"2006","unstructured":"Fukuda T, Roberts A, Ahearn M, Zaal K, Ralston E, Plotz PH et al. Autophagy and lysosomes in Pompe disease. Autophagy 2006; 2: 318\u2013320.","journal-title":"Autophagy"},{"key":"BFgt2009160_CR40","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/ana.20807","volume":"59","author":"T Fukuda","year":"2006","unstructured":"Fukuda T, Ewan L, Bauer M, Mattaliano RJ, Zaal K, Ralston E et al. Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol 2006; 59: 700\u2013708.","journal-title":"Ann Neurol"},{"key":"BFgt2009160_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4161\/auto.4591","volume":"3","author":"N Raben","year":"2007","unstructured":"Raben N, Takikita S, Pittis MG, Bembi B, Marie SKN, Roberts A et al. Deconstructing Pompe disease by analyzing single muscle fibers. To see a world in a grain of sand. Autophagy 2007; 3: 546\u2013552.","journal-title":"Autophagy"},{"key":"BFgt2009160_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/auto.5.1.7293","volume":"5","author":"N Raben","year":"2009","unstructured":"Raben N, Baum R, Schreiner C, Takikita S, Mizushima N, Ralston E et al. When more is less excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease. Autophagy 2009; 5: 1\u20133.","journal-title":"Autophagy"},{"key":"BFgt2009160_CR43","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","volume":"14","author":"T Fukuda","year":"2006","unstructured":"Fukuda T, Ahearn M, Roberts A, Mattaliano RJ, Zaal K, Ralston E et al. Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease. Mol Ther 2006; 14: 831\u2013839.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR44","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/jgm.1372","volume":"11","author":"B Sun","year":"2009","unstructured":"Sun B, Zhang H, Bird A, Li S, Young SP, Koeberl DD . Impaired clearence of accumulated lysosomal glycogen in advanced Pompe disease despite high-level vector mediated transgene expression. J Gene Med 2009; 11: 913\u2013920.","journal-title":"J Gene Med"},{"key":"BFgt2009160_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ymthe.2004.09.017","volume":"11","author":"N Raben","year":"2005","unstructured":"Raben N, Fukuda T, Gilbert AL, Jong D, Thurberg BL, Mattaliano RJ et al. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. Mol Ther 2005; 11: 48\u201356.","journal-title":"Mol Ther"},{"key":"BFgt2009160_CR46","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1089\/104303401750195917","volume":"12","author":"EY Ding","year":"2001","unstructured":"Ding EY, Hodges BL, Hu H, McVie-Wylie AJ, Serra D, Migone FK et al. Long-term efficacy after [E1\u2212, polymerase\u2212] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice. Hum Gene Ther 2001; 12: 955\u2013965.","journal-title":"Hum Gene Ther"},{"key":"BFgt2009160_CR47","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1042\/BJ20050364","volume":"389","author":"Y Zhu","year":"2005","unstructured":"Zhu Y, Li X, McVie-Wylie A, Jiang C, Thurberg BL, Raben N et al. Carbohydrate-remodelled acid \u00e1-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice. Biochem J 2005; 389: 619\u2013628.","journal-title":"Biochem J"},{"key":"BFgt2009160_CR48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJM200103153441102","volume":"344","author":"LJ West","year":"2001","unstructured":"West LJ, Pollock-Barziv SM, Dipchand AI, Lee KJ, Cardella CJ, Benson LN et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001; 344: 793\u2013800.","journal-title":"N Engl J Med"},{"key":"BFgt2009160_CR49","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1542\/peds.2007-2222","volume":"122","author":"Y-H Chien","year":"2008","unstructured":"Chien Y-H, Chiang S-C, Zhang XK, Keutzer J, Lee N-C, Huang A-C et al. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan Screening Program. Pediatrics 2008; 122: e39\u2013e45.","journal-title":"Pediatrics"},{"key":"BFgt2009160_CR50","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1538-7933.2004.00671.x","volume":"2","author":"S Madoiwa","year":"2004","unstructured":"Madoiwa S, Yamauchi T, Hakamata Y, Kobayashi E, Arai M, Sugo T et al. Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A. J Thromb Haemost 2004; 2: 754\u2013762.","journal-title":"J Thromb Haemost"},{"key":"BFgt2009160_CR51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"301","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 301: 415\u2013419.","journal-title":"Science"},{"key":"BFgt2009160_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1079-9796(03)00062-7","volume":"31","author":"R Stripecke","year":"2003","unstructured":"Stripecke R, Koya RC, Ta HQ, Kasahara N, Levine AM . The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors. Blood Cells Mol Dis 2003; 31: 28\u201337.","journal-title":"Blood Cells Mol Dis"},{"key":"BFgt2009160_CR53","doi-asserted-by":"publisher","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","volume":"273","author":"N Raben","year":"1998","unstructured":"Raben N, Nagaraju K, Lee E, Kessler P, Byrnei B, Lee L et al. Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem 1998; 273: 19086\u201319092.","journal-title":"J Biol Chem"},{"key":"BFgt2009160_CR54","first-page":"328","volume":"49","author":"MS Sands","year":"1999","unstructured":"Sands MS, Barker JE . Percutaneous intravenous injection in neonatal mice. Lab Anim Sci 1999; 49: 328\u2013330.","journal-title":"Lab Anim Sci"},{"key":"BFgt2009160_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","volume":"11","author":"B Sun","year":"2005","unstructured":"Sun B, Zhang H, Franco LM, Young SP, Schneider A, Bird A et al. Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II. Mol Ther 2005; 11: 57\u201365.","journal-title":"Mol Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2009160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2009160","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2009160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T08:09:58Z","timestamp":1648541398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2009160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,24]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["BFgt2009160"],"URL":"https:\/\/doi.org\/10.1038\/gt.2009.160","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,24]]},"assertion":[{"value":"6 May 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The department of Genetic Diseases of the Jikei University School of Medicine receives grants from the Genzyme Corporation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}